[Skip to Content]
[Skip to Content Landing]
Article
January 1990

0.008% Timolol Ophthalmic SolutionA Minimal-Effect Dose in a Normal Volunteer Model

Author Affiliations

From the Wills Eye Hospital and Department of Ophthalmology (Drs Mottow-Lippa, Lippa, and Naidoff) and the Division of Clinical Pharmacology (Ms Clementi and Dr Bjornsson), Jefferson Medical College, Philadelphia, Pa, and Clinical Research and Clinical Pharmacology, Merck Sharp & Dohme Research Laboratories, West Point, Pa (Drs Lippa and Jones).

Arch Ophthalmol. 1990;108(1):61-64. doi:10.1001/archopht.1990.01070030067030
Abstract

• A double-masked, randomized, placebo-controlled, rising-dose, single-dose study was undertaken to assess the effect of low concentrations of timolol maleate ophthalmic solution (0.008%, 0.025%, 0.08%, and 0.25%) on intraocular pressure and its diurnal variation in healthy, normal volunteers. A single dose of 0.008% timolol exhibits a definite but minimal-effect on intraocular pressure in this normal volunteer model, causing a significant peak mean decrease in intraocular pressure from its value immediately pre-dose. This decrease was 1.8 mm Hg (a peak mean percent decrease of 12.8%) at 2 hours postdose compared with an increase of 0.1 mm Hg (+2.5%) during a pre-study curve due to normal diurnal variation. One drop of 0.008% solution represents a single dose of approximately 2.5 μg of timolol. A slight contralateral ocular hypotensive effect appears to be present for 0.25% timolol at 2 hours postdose although it just failed to reach statistical significance.

References
1.
Kaufman H.  Timolol maleate . Ophthalmology . 1980;87:164-168.Article
2.
Zimmerman TJ, Kass MA, Yablonski ME, Becker B.  Timolol maleate: safety and efficacy . Arch Ophthalmol . 1979;97:656-658.Article
3.
Zimmerman TJ, Kaufman HE.  Timolol: dose response and duration of action . Arch Ophthalmol . 1977;95:605-607.Article
4.
Katz IM, Hubbard WA, Getson AJ, Gould AL.  Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution . Invest Ophthalmol Vis Sci . 1976;15:489-492.
5.
Katz IM, Berger ET.  Effects of iris pigmentation on response of ocular pressure to timolol . Surv Ophthalmol . 1979;23:395-398.Article
6.
Kitazawa Y, Tsuchisaka H, Horie T, Takahashi O.  The effect of timolol ophthalmic solution on intraocular pressure of normal subjects: the effect of single topical administration . Ganka Rinsho Iho . 1980;74:158-162.
7.
Sugiyama K, Kawai K, Kitazawa Y.  The effect of d-timolol on intraocular pressure in normal subjects . Nippon Ganka Gakkai Zasshi . 1986;90:866-870.
8.
Demailly P.  A short-term study . In: Timolol Maleate Ophthalmic Solution in the Treatment of Glaucoma: Selected Papers From the Proceedings of the International Symposium on Glaucoma, XXIII International Congress of Ophthalmology, Kyoto, Japan, May 12, 1978 . Rahway, NJ: Merck Sharp & Dohme International; 1978:16-17.
9.
Fujino Y, Shirato S, Kitazawa Y.  The hypotensive effects of timolol and epinephrine—first report—independent and combined use . Nippon Ganka Gakkai Zasshi . 1981;85:2076-2081.
10.
Alm A, Wickstrom CP, Tornquist P.  Initial and long-term effects of metoprolol and timolol on the intraocular pressure: a comparison in healthy subjects . Acta Ophthalmol (Copenh) . 1981;59:510-516.Article
11.
Brazier DJ, Smith SE.  Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers . Br J Ophthalmol . 1988;72:101-103.Article
12.
Dailey RA, Brubaker RF, Bourne WM.  The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects . Am J Ophthalmol . 1982;93:232-237.
13.
Yablonski ME, Zimmerman TJ, Waltman SR, Becker B.  A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics . Exp Eye Res . 1978;27:135-142.Article
14.
Zimmerman TJ, Harbin R, Pett M, Kaufman HE.  Timolol and outflow of facility . Invest Ophthalmol Vis Sci . 1977;16:623-624.
15.
Coakes RI, Brubaker RF.  The mechanism of timolol in lowering intraocular pressure in the normal eye . Arch Ophthalmol . 1978;96:2045-2048.Article
16.
Affrime MB, Lowenthal DT, Tobert JA, et al.  Dynamics and kinetics of ophthalmic timolol . Clin Pharmacol Ther . 1980;27:471-477.Article
17.
Alvan G, Calissendorff B, Seideman P, Widmark K, Widmark G.  Absorption of ocular timolol . Clin Pharmacokinet . 1980;5:95-100.Article
18.
Rowley S, Staunton JE, Tisch A, et al.  A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects . Br J Ophthalmol . 1981;65:536-538.Article
19.
Martin XD, Rabineau PA.  Intraocular pressure effects of timolol after unilateral instillation . Ophthalmology . 1988;95:1620-1623.Article
20.
Krieglstein GK.  The effect of timolol eye drops on intraocular pressure in glaucoma simplex . Klin Monatsbl Augenheilkd . 1978;172:677-685.
21.
Brubaker RF, Schlecht LP.  The effects of withdrawal of timolol in chronically treated glaucoma patients . Invest Ophthalmol Vis Sci . 1987;28( (suppl) ):377.
×